PENN MEDICINE CO-INVESTMENT PROGRAM
Penn Medicine Co-Investment Program makes investments in faculty-driven cell therapy, gene therapy, and connected health companies
PENN MEDICINE CO-INVESTMENT PROGRAM
Industry:
Biopharma Biotechnology Health Care Life Science
Status:
Active
Similar Organizations
Accelerate@Babraham
Accelerate@Babraham is the incubation programme of the Babraham Research Campus.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Molecular Forecaster
Molecular Forecaster builds software for drug discovery, metabolism prediction, library design & small molecule asymmetric catalyst design.
Recognify Life Sciences
Recognify Life Sciences is an entity developing a treatment for Cognitive Impairment associated with Schizophrenia ("CIAS").
Reliance Life Sciences
Reliance Life Sciences is a diverse and integrated biotechnology initiative of the Reliance Group of companies
Sharp Corp
Sharp Corp provides contract packaging services for Rx, biotechnology, OTC/nutritional, clinical packaging, animal health.
Global Health Investment Fund (GHIF)
Impact investment fund established to finance late-stage development of new drugs, vaccines and diagnostics for public health challenges
Tricol Biomedical Inc
Tricol Biomedical develops advanced wound care, hemorrhage, infection control & wound management technologies.
Current Employees Featured
Carter Caldwell Program Director @ Penn Medicine Co-Investment Program
Program Director
2019-04-01
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Vittoria Biotherapeutics | Penn Medicine Co-Investment Program investment in Seed Round - Vittoria Biotherapeutics | 10 M USD |
| 2021-11-30 | CareAlign | Penn Medicine Co-Investment Program investment in Seed Round - CareAlign | 2.3 M USD |
| 2021-05-18 | Interius BioTherapeutics | Penn Medicine Co-Investment Program investment in Series A - Interius BioTherapeutics | 76 M USD |
| 2021-03-01 | Carisma Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Carisma Therapeutics | 12 M USD |
| 2020-03-13 | Interius BioTherapeutics | Penn Medicine Co-Investment Program investment in Venture Round - Interius BioTherapeutics | 5.5 M USD |
| 2019-10-31 | Tmunity Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Tmunity Therapeutics | 75 M USD |
| 2019-09-17 | Linnaeus Therapeutics | Penn Medicine Co-Investment Program investment in Series B - Linnaeus Therapeutics | 12 M USD |
| 2019-01-03 | Cabaletta Bio | Penn Medicine Co-Investment Program investment in Series B - Cabaletta Bio | 50 M USD |
| 2018-09-07 | Linnaeus Therapeutics | Penn Medicine Co-Investment Program investment in Series A - Linnaeus Therapeutics | 4.4 M USD |
| 2018-06-27 | Carisma Therapeutics | Penn Medicine Co-Investment Program investment in Series A - Carisma Therapeutics | 53 M USD |
More informations about "Penn Medicine Co-Investment Program"
Penn Medicine Co-Investment Program continues to …
Jun 21, 2022 Launched in March 2018, the Penn Medicine Co-Investment Program assists faculty entrepreneurs as they move along the path to venture creation and permanent financing through active support and early stage …See details»
The Path from Innovation to Implementation - Penn Medicine
Penn Medicine Co-Investment Program - Crunchbase
Penn Medicine Co-Investment Program focuses on early-stage investments in biotechnology, healthcare, and therapeutics industries, primarily in Philadelphia and Haddonfield, United …See details»
Penn Medicine Co-Investment Program: Fund Performance
Penn Medicine Co-Investment Program is a co-investment fund managed by Penn Medicine Co-Investment Program. The fund is located in Philadelphia, Pennsylvania. Contact InformationSee details»
R. Carter Caldwell - Penn Center for Innovation
As the Penn Medicine Co-Investment Program Director, Carter leads Penn Medicine’s investments in the cell therapy, gene therapy, mRNA, lipid nanoparticle, and connected health sectors. Utilizing multiple decades of …See details»
Carter Caldwell - Program Director @ Penn Medicine …
As the Penn Medicine Co-Investment Program’s Director, Carter drives Penn Medicine's investments in the cell therapy, gene therapy, mRNA, lipid nanoparticle, and connected health spinouts. Utilizing multiple decades of …See details»
Carter Caldwell of the Penn Medicine Co-Investment …
Apr 20, 2023 In 2019, I joined a brand new investment vehicle that Penn Medicine at the University of Pennsylvania set up to fund spinouts that emerge from faculty research.See details»
Penn Medicine Co-Investment Program - raizer.app
Penn Medicine Co-Investment Program invests in cell therapy, gene therapy, mRNA, lipid nanoparticle, and connected health spinouts from Penn Learn which startups Penn Medicine …See details»
Penn and Greater Philadelphia’s Entrepreneurial …
The Penn Medicine Co-Investment Program invests capital alongside institutional investors to fund faculty-driven cell therapy, gene therapy, mRNA, and connected health companies based here in Philadelphia. The Milken-Penn GSE …See details»
Carter Caldwell ’95: Investing in Health Care Research and …
Jun 19, 2020 Shipley Changemaker, Carter Caldwell ’95, now works for his alma mater, the University of Pennsylvania, where he graduated in 1999 with a degree in Philosophy, …See details»
Penn Medicine Co-Investment Program - Crunchbase
Penn Medicine Co-Investment Program has made 5 diversity investments. Their most recent diversity investment was on Nov 30, 2021 , when CareAlign raised obfuscatedSee details»
Penn Medicine Co-Investment Program - PitchBook
Jan 26, 2023 Penn Medicine Co-Investment Program's latest investment was on 12-Aug-2024 in Linnaeus Therapeutics, a company within the Drug Discovery industry. Data Transparency. …See details»
Carter Caldwell | The Venture Debt Conference
As the Penn Medicine Co-Investment Program Director at the University of Pennsylvania, Carter leads Penn Medicine's investments in the cell therapy, gene therapy, mRNA, lipid …See details»
PENN MEDICINE CO-INVESTMENT PROGRAM DIRECTOR - Inside …
Duties: The Program Director will manage a co-investment pilot Program which will enable University participation in early financing rounds in companies created through licenses of …See details»
Penn Medicine and Wharton Social Impact Initiative Launch New …
Aug 31, 2021 The organization consists of the University of Pennsylvania Health System (UPHS) and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the …See details»
PCI's Carter Caldwell Is Interviewed on Launching a Startup - Penn ...
May 10, 2023 PCI’s Carter Caldwell, program director for the Penn Medicine Co-Investment Program, discussed his entrepreneurial career and shared advice for others looking to start …See details»
Penn Medicine Investment Program Manager - Philadelphia
Job title: penn medicine co-investment program director Description . The University of Pennsylvania is seeking a highly experienced and skilled individual to manage the Co …See details»
CAREs grant helps patients share their own health care story
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and …See details»
How Corporatization Continues to Change U.S. Health Care
Mar 13, 2025 In his 1984 Pulitzer Prize-winning book, The Social Transformation of American Medicine, Princeton sociology professor Paul Starr predicted a national shift from a physician …See details»
Penn Medicine Co-Investment Program - Crunchbase
Penn Medicine Co-Investment Program is funding platform for cell and gene therapy, mRNA, lipid nanoparticle, and health technologies.See details»